Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset ...
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- BVS Bioventus-19.8% 14d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Bioventus belongs to, so it often moves with news about it.
- SYK Stryker+23.0% 30d
Stryker is a peer of Bioventus in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+10.8% 30d
3M is a peer of Bioventus in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific+1.6% 30d
Boston Scientific is a peer of Bioventus in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+18.2% 30d
Becton, Dickinson and is a peer of Bioventus in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline+8.7% 16d
Medline is a peer of Bioventus in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BVS | +9.59% | +13.36% | base | -16.71% | -13.13% | -18.73% | -19.22% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| SYK | -1.81% | +1.47% | base | +1.13% | +10.68% | +9.15% | +6.17% |
| MMM | -3.78% | -0.57% | base | -0.75% | +8.77% | +5.24% | +3.83% |
| BSX | +1.68% | -3.72% | base | -1.87% | +3.34% | +0.65% | -3.56% |
| BDX | -1.80% | -0.13% | base | -0.19% | +5.26% | +7.48% | +6.72% |
| MDLN | -3.73% | -4.90% | base | +1.40% | +20.05% | +18.28% | +17.87% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset ... Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| BDX | that day | -0.19% | final price |
| BDX | the next day | +5.26% | final price |
| BDX | two days later | +7.48% | final price |
| BDX | three days later | +6.72% | final price |
| BDX | three days earlier | -0.13% | final price |
| BDX | five days earlier | -1.80% | final price |
| BSX | that day | -1.87% | final price |
| BSX | the next day | +3.34% | final price |
| BSX | two days later | +0.65% | final price |
| BSX | three days later | -3.56% | final price |
| BSX | three days earlier | -3.72% | final price |
| BSX | five days earlier | +1.68% | final price |
| BVS | that day | -16.71% | final price |
| BVS | the next day | -13.13% | final price |
| BVS | two days later | -18.73% | final price |
| BVS | three days later | -19.22% | final price |
| BVS | three days earlier | +13.36% | final price |
| BVS | five days earlier | +9.59% | final price |
| MDLN | that day | +1.40% | final price |
| MDLN | the next day | +20.05% | final price |
| MDLN | two days later | +18.28% | final price |
| MDLN | three days later | +17.87% | final price |
| MDLN | three days earlier | -4.90% | final price |
| MDLN | five days earlier | -3.73% | final price |
| MMM | that day | -0.75% | final price |
| MMM | the next day | +8.77% | final price |
| MMM | two days later | +5.24% | final price |
| MMM | three days later | +3.83% | final price |
| MMM | three days earlier | -0.57% | final price |
| MMM | five days earlier | -3.78% | final price |
| SYK | that day | +1.13% | final price |
| SYK | the next day | +10.68% | final price |
| SYK | two days later | +9.15% | final price |
| SYK | three days later | +6.17% | final price |
| SYK | three days earlier | +1.47% | final price |
| SYK | five days earlier | -1.81% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Congressional trades in the stocks in this story
- Rep. Thomas H. Kean Jr sold Stryker (SYK), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 55 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 60 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 61 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset ...” scores 12 out of 100. The score uses 1 sources.